The largest database of trusted experimental protocols

2 protocols using glutamaxtmsupplement hepes

1

Differentiation of hiPSCs into cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
hiPSCs were cultured until 80–90% confluency and washed with dPBS (Gibco, 14190094). The cells were then provided with RMPI++ (bare RPMI-1640-Medium-GlutaMAXTMSupplement-HEPES (Gibco, 72400-021) supplemented with 0.5 mg/mL human recombinant albumin (Sigma, A9731), 0.2 mg/mL L-ascorbic acid 2-phosphate (Sigma, A8960)), and 4 µM CHIR99021 (Sigma, 361559). After 48 h, the medium was replaced with RMPI++ and 5 µM IWP2 (Sigma, 681671) after a single rinse with bare RMPI-1640. Then, the cells were refreshed every other day with RMPI++, for 4 days. Thereafter, the cells were cultured every 3–4 days with bare RMPI, supplemented with B-27TM Supplement (Gibco, 17504001). Prior to the optical experiments, the hiPSC-CMs were dissociated with TrypLE Select Enzyme without phenol red (Gibco, A1217703) and seeded on GeltrexTM coated coverslips.
+ Open protocol
+ Expand
2

Allogeneic MLR Potency Assay for UC-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
MLR potency assay was performed according to Nicotra et al. [16 (link)]. MLR assay was performed on UC-MSCs both in a resting state (NT) and after priming for 48 h with IFNγ, TNFα and IFNγ + TNFα. Briefly, peripheral blood mononuclear cells (PBMCs) pooled from 10 healthy donors and labeled with the CellTraceTM Violet (CTV) Cell Proliferation Kit (Invitrogen, Ref C34557) were co-cultured with UC-MSCs at 0:1 (control), 1:10, 1:30, 1:100, 1:300 and 1:1000 UC-MSCs:PBMC ratio with a constant amount of PBMC (3 × 105) and a decreasing amount of UC-MSCs from 3 × 104 down to 3 × 102.
Cells were co-cultured in a culture medium composed of Roswell Park Memorial Institute (RPMI) Medium 1640, GlutaMAXTM Supplement, HEPES (Gibco, Ref 72400-013), 10% human A/B serum (Eurobio, Ref CAEHUM010U), 1% Amphotericin B/Penicillin/Streptomycin (Gibco, Ref 15240062), and 10 UI/mL Heparin (PanPharma, Ref 5520508) at 37 °C, 5% CO2 for 7 days. At day 4 ± 1, 50 µL of culture medium was added. At day 7, cells were labeled with 5 µL of human antibodies anti-CD3 PE (BD Biosciences, Ref 345765), anti-CD45 FITC (BD Biosciences, Ref 345808) and 7-AAD viability dye (Beckman Coulter, Ref A07704) for 15 min at 4 °C, protected from light. Cells were washed in PBS 1X before acquisition on the Attune NxT™ Thermofisher® Flow Cytometer and analyzed using Attune NxT™ software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!